192 related articles for article (PubMed ID: 30922137)
1. Serum level of miR-142-3p predicts prognostic outcome for colorectal cancer following curative resection.
Gao W; Pang D; Yu S
J Int Med Res; 2019 May; 47(5):2116-2125. PubMed ID: 30922137
[TBL] [Abstract][Full Text] [Related]
2. Low Serum Levels of miR-101 Are Associated with Poor Prognosis of Colorectal Cancer Patients After Curative Resection.
He D; Yue Z; Li G; Chen L; Feng H; Sun J
Med Sci Monit; 2018 Oct; 24():7475-7481. PubMed ID: 30341274
[TBL] [Abstract][Full Text] [Related]
3. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
Sahami-Fard MH; Kheirandish S; Sheikhha MH
Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
[TBL] [Abstract][Full Text] [Related]
4. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
Lv ZC; Fan YS; Chen HB; Zhao DW
Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
[TBL] [Abstract][Full Text] [Related]
5. Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.
Ng L; Wan TM; Man JH; Chow AK; Iyer D; Chen G; Yau TC; Lo OS; Foo DC; Poon JT; Leung WK; Pang RW; Law WL
Oncotarget; 2017 Apr; 8(16):27393-27400. PubMed ID: 28404964
[TBL] [Abstract][Full Text] [Related]
6. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of microRNA-1180-3p for colorectal cancer and effect of its alteration on cell function.
Li C; Jin W; Zhang D; Tian S
Bioengineered; 2021 Dec; 12(2):10491-10500. PubMed ID: 34723759
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of serum microRNA-21 in colorectal cancer.
Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
[TBL] [Abstract][Full Text] [Related]
11. Circulating miR-449a predicts survival outcome for colorectal cancer following curative resection: An observational study.
Fu D; Chen Y; Xu D
Medicine (Baltimore); 2021 Apr; 100(15):e25022. PubMed ID: 33847612
[TBL] [Abstract][Full Text] [Related]
12. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.
Toiyama Y; Takahashi M; Hur K; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
J Natl Cancer Inst; 2013 Jun; 105(12):849-59. PubMed ID: 23704278
[TBL] [Abstract][Full Text] [Related]
13. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
14. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z
Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615
[TBL] [Abstract][Full Text] [Related]
15. Validation of miR-1228-3p as Housekeeping for MicroRNA Analysis in Liquid Biopsies from Colorectal Cancer Patients.
Duran-Sanchon S; Vila-Navarro E; Marcuello M; Lozano JJ; Muñoz J; Cubiella J; Diez MS; Bujanda L; Lanas A; Jover R; Hernández V; Quintero E; Herreros-Villanueva M; Martín AC; Pérez-Palacios R; Arroyo R; Castells A; Gironella M
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31877644
[TBL] [Abstract][Full Text] [Related]
16. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
Gao Y; Liu Y; Du L; Li J; Qu A; Zhang X; Wang L; Wang C
Med Oncol; 2015 Jan; 32(1):362. PubMed ID: 25502080
[TBL] [Abstract][Full Text] [Related]
18. Identification of a four-microRNA panel in serum as promising biomarker for colorectal carcinoma detection.
Huang G; Wei B; Chen Z; Wang J; Zhao L; Peng X; Liu K; Lai Y; Ni L
Biomark Med; 2020 Jun; 14(9):749-760. PubMed ID: 32672054
[No Abstract] [Full Text] [Related]
19. Clinical Potentials of miR-576-3p, miR-613, NDRG2 and YKL40 in Colorectal Cancer Patients.
Eldaly MN; Metwally FM; Shousha WG; El-Saiid AS; Ramadan SS
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1689-1695. PubMed ID: 32592365
[TBL] [Abstract][Full Text] [Related]
20. Serum
Wang N; Zeng L; Li Z; Zhen Y; Chen H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2650-2653. PubMed ID: 31240955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
